Closed
SectorHealthcare
588.04 0.5
24h
Min
584.08
Max
600.61
Income | -423M 918M |
---|---|
Sales | 69M 3.8B |
P/E Sector Avg | 14.641 57.333 |
EPS | 12.07 |
Dividend yield | 0.63 |
Profit margin | 24.219 |
Employees | 15,106 |
EBITDA | -534M 1.1B |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +53.58% upside |
Dividend yield Sector Avg | 0.63% 2.63% |
---|---|
Next Earnings | 29 kwi 2025 |
Market Cap | -13B 62B |
---|---|
Previous open | 587.54 |
Previous close | 588.04 |
By Acuity
31%
69%
96 / 382 Ranking in Healthcare
By Trading Central
Confidence
Strong Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 899.2 USD 53.58%
High 1,120 USD
Low 547 USD
Based on 21 Wall Street analysts offering 12 month price targets forRegeneron Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$